TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) EBIT Margin (2023)

Updated

TFA Therapeutics (RAJAF) recorded EBIT Margin of -11.33% in FY2025, up 3.34 percentage points from -14.67% in FY2024.

Analysis

TFA Therapeutics (RAJAF) EBIT Margin (2023) Analysis & Trends

Starting with FY2020, TFA Therapeutics' EBIT Margin history includes 6 years.

  • Annual EBIT Margin has a five-year change of -17.81 percentage points (FY2020 to FY2025).
  • Annual EBIT Margin has ranged from -778.78% in FY2022 to 25.82% in FY2023 over the past five years.
  • Per Business Quant data, RAJAF's EBIT Margin was -14.67% in FY2024 (-40.49 pp), 25.82% in FY2023 (+804.60 pp), -778.78% in FY2022 (-765.20 pp) and -13.58% in FY2021 (-20.06 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn 18.63%
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn 18.95%
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn 17.67%
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn -1.08%
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn 15.11%
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn 18.07%
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn 24.33%
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn 21.37%
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn 14.62%
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 38.18%
API Access

TFA Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=RAJAF&period=max&api_key=YOUR_API_KEY